January 6, 2010
In Melilla [ Spain] have also detected a mutation in patients with influenza A virus.
http://translate.googleusercontent.com/ ... YUk8F8UQpAFirst case of virus mutation Influenza A in Melilla
The National Epidemiological Surveillance Network has discovered a mutation of the influenza virus A, D222G, which the National Microbiology Center (NMC) has found its presence in 34 patients, one of Melilla. Castilla-La Mancha, Ceuta, Galicia, Madrid, Navarra. Andalusia and Asturias has also been identified in patients. This mutation has been detected in other countries around the world, although its significance is not fully defined, could favor the virus were 'easier to infect lower areas of the respiratory tract, "the Surveillance Network reported in its latest report, on the week of 20 to 26 December. This mutation affects RNA virus envelope in a place near the junction of the receiver to the bronchial epithelial cell, although "the significance of this change in the receptor-binding site is highly questionable, 'the authors the report, "the data of patients who present can be of great help in trying to interpret if you have some functionality.
Furthermore, this center under the Carlos III also reports of two cases known as oseltamivir-resistant virus, the antiviral used to combat new flu Roche markets under the name 'Tamilfu'.
Pocas vacunas Few vaccines
Given these data, the Minister of Social Welfare and Health of the Autonomous City of Melilla regretted that vaccinations against influenza A virus in Melilla are being so low, since, according to data handled by Maria Antonia Garbín until currently only used 2,000 of the 12,000 vaccines that are available in the city.
While acknowledging that the dates of vaccination are "very bad", the adviser expects to launch an information campaign to encourage citizen prevention-risk groups.
For the time vaccines are available in all health centers both public and private, but in the event that finally it was never used this season, Garbín anticipated that all those responsible for the health of the various Spanish communities together to decide what do with the surplus. He reminded the adviser that the biggest problem is that the vaccine does not work from one year to another because the strain is different, although I trust that, with the upcoming and predictable falling temperatures, people valued the option of vaccination.
============================
different version of same story ..... the first one and the second one are inconsistent wrt which mutations are D225E and how many/where are D225G cases.
http://www.melillahoy.es/noticia/61754/ ... gripe.htmlThe National Epidemiological Surveillance Center of the Health Institute Carlos III reports that have already been registered in Spain more than 40 cases of mutations of the H1N1 virus that causes influenza, among which would be the "D222E", which has found its presence in 34 patients from Castilla-La Mancha, Ceuta, Galicia, Madrid, Melilla and Navarra. In addition, Andalusia and Asturias have identified in 6 and 1 cases respectively. In Melilla have been vaccinated only two thousand people, despite being available over twelve thousand doses.
Councilor Welfare and Health, Maria Antonia Garbin, said the [anti- vaccination campaign against influenza A] is doing "evil", and this is because even though it gained about twelve thousand doses have been distributed at health centers and insurance, just "two thousand people have been vaccinated. The figures are below the norm in the rest of the country.
[I added the anti- I think that this is what was meant here]Considers that one of the causes that are not vaccinated Melilla and also a decline in the number of infections, high temperatures are still found in Melilla. In fact according to the National Epidemiological Surveillance of the Health Institute Carlos III, the reported incidence rate of influenza is in Melilla in 28.18 cases per 100,000 population, below the national average which is 40.8 cases .
But Garbín said that we must not drop our guard, because from now is expected to reach the winter weather will cause an increase in flu cases. "We will continue the campaign until being told otherwise by health authorities.
A journalists' questions, said Garbín not yet decided what to do with leftover doses, and that decision will be adopted in the relevant body in Madrid with the participation of all communities. One solution that has considered is to send low-income countries. What is certain is that these vaccines will no longer be operational next year, driven by the mutation that is prone to the flu virus, both A and B.
Recognized Garbín have been detected in our country mutations of H1N1 (influenza virus) that are being analyzed by the Carlos III Institute, without which for the moment had been issued special rules to follow.
Mutations
Just this week a man aged 31 died in Andalusia from complications from a mutation of the influenza virus A, "D222G", becoming the second death in Spain by this alteration of the H1N1 virus first detected in Norway According to the latest weekly report from the National Epidemiological Surveillance Network.
This patient, who had no medical history, eventually dying of multiple organ failure after several complications, reports the monitoring system by Sentinel Physicians. However, Health Ministry sources claimed that this mutation is "expected" behavior according to each year have the flu virus.
This mutation has been detected in other countries and, although its significance is not fully defined, could enhance the virus would "infect it easier to lower areas of the respiratory tract, the Surveillance Network reported in its latest report.
In addition, the National Epidemiological Surveillance Network reported more than 40 mutations of
"D222E" and that his presence was found in about 34 patients from the regions of Castilla-La Mancha, Ceuta, Galicia, Madrid, Melilla and Navarra.
===============
Spain seems to be more upfront about discussing the strains of virus that show mutations. They have reported two deaths, both with the D225G change, and 40 (in 34 patients?) mutations with D225E with no deaths reported.